Cargando…

Case Report: Heterozygous Germline Variant in EIF6 Additional to Biallelic SBDS Pathogenic Variants in a Patient With Ribosomopathy Shwachman–Diamond Syndrome

Background: Shwachman–Diamond syndrome (SDS) is a rare autosomal recessive ribosomopathy mainly characterized by exocrine pancreatic insufficiency, skeletal alterations, neutropenia, and a relevant risk of hematological transformation. At least 90% of SDS patients have pathogenic variants in SBDS, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Taha, Ibrahim, Foroni, Selena, Valli, Roberto, Frattini, Annalisa, Roccia, Pamela, Porta, Giovanni, Zecca, Marco, Bergami, Elena, Cipolli, Marco, Pasquali, Francesco, Danesino, Cesare, Scotti, Claudia, Minelli, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411639/
https://www.ncbi.nlm.nih.gov/pubmed/36035165
http://dx.doi.org/10.3389/fgene.2022.896749
_version_ 1784775313357537280
author Taha, Ibrahim
Foroni, Selena
Valli, Roberto
Frattini, Annalisa
Roccia, Pamela
Porta, Giovanni
Zecca, Marco
Bergami, Elena
Cipolli, Marco
Pasquali, Francesco
Danesino, Cesare
Scotti, Claudia
Minelli, Antonella
author_facet Taha, Ibrahim
Foroni, Selena
Valli, Roberto
Frattini, Annalisa
Roccia, Pamela
Porta, Giovanni
Zecca, Marco
Bergami, Elena
Cipolli, Marco
Pasquali, Francesco
Danesino, Cesare
Scotti, Claudia
Minelli, Antonella
author_sort Taha, Ibrahim
collection PubMed
description Background: Shwachman–Diamond syndrome (SDS) is a rare autosomal recessive ribosomopathy mainly characterized by exocrine pancreatic insufficiency, skeletal alterations, neutropenia, and a relevant risk of hematological transformation. At least 90% of SDS patients have pathogenic variants in SBDS, the first gene associated with the disease with very low allelic heterogeneity; three variants, derived from events of genetic conversion between SBDS and its pseudogene, SBDSP1, provided the alleles observed in about 62% of SDS patients. Methods: We performed a reanalysis of the available WES files of a group of SDS patients with biallelic SBDS pathogenic variants, studying the results by next bioinformatic and protein structural analysis. Parallelly, careful clinical attention was given to the patient focused in this study. Results: We found and confirmed in one SDS patient a germline heterozygous missense variant (c.100T>C; p.Phe34Leu) in the EIF6 gene. This variant, inherited from his mother, has a very low frequency, and it is predicted as pathogenic, according to several in silico prediction tools. The protein structural analysis also envisages the variant could reduce the binding to the nascent 60S ribosomal. Conclusion: This study focused on the hypothesis that the EIF6 germline variant mimics the effect of somatic deletions of chromosome 20, always including the locus of this gene, and similarly may rescue the ribosomal stress and ribosomal dysfunction due to SBDS mutations. It is likely that this rescue may contribute to the stable and not severe hematological status of the proband, but a definite answer on the role of this EIF6 variant can be obtained only by adding a functional layer of evidence. In the future, these results are likely to be useful for selected cases in personalized medicine and therapy.
format Online
Article
Text
id pubmed-9411639
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94116392022-08-27 Case Report: Heterozygous Germline Variant in EIF6 Additional to Biallelic SBDS Pathogenic Variants in a Patient With Ribosomopathy Shwachman–Diamond Syndrome Taha, Ibrahim Foroni, Selena Valli, Roberto Frattini, Annalisa Roccia, Pamela Porta, Giovanni Zecca, Marco Bergami, Elena Cipolli, Marco Pasquali, Francesco Danesino, Cesare Scotti, Claudia Minelli, Antonella Front Genet Genetics Background: Shwachman–Diamond syndrome (SDS) is a rare autosomal recessive ribosomopathy mainly characterized by exocrine pancreatic insufficiency, skeletal alterations, neutropenia, and a relevant risk of hematological transformation. At least 90% of SDS patients have pathogenic variants in SBDS, the first gene associated with the disease with very low allelic heterogeneity; three variants, derived from events of genetic conversion between SBDS and its pseudogene, SBDSP1, provided the alleles observed in about 62% of SDS patients. Methods: We performed a reanalysis of the available WES files of a group of SDS patients with biallelic SBDS pathogenic variants, studying the results by next bioinformatic and protein structural analysis. Parallelly, careful clinical attention was given to the patient focused in this study. Results: We found and confirmed in one SDS patient a germline heterozygous missense variant (c.100T>C; p.Phe34Leu) in the EIF6 gene. This variant, inherited from his mother, has a very low frequency, and it is predicted as pathogenic, according to several in silico prediction tools. The protein structural analysis also envisages the variant could reduce the binding to the nascent 60S ribosomal. Conclusion: This study focused on the hypothesis that the EIF6 germline variant mimics the effect of somatic deletions of chromosome 20, always including the locus of this gene, and similarly may rescue the ribosomal stress and ribosomal dysfunction due to SBDS mutations. It is likely that this rescue may contribute to the stable and not severe hematological status of the proband, but a definite answer on the role of this EIF6 variant can be obtained only by adding a functional layer of evidence. In the future, these results are likely to be useful for selected cases in personalized medicine and therapy. Frontiers Media S.A. 2022-08-12 /pmc/articles/PMC9411639/ /pubmed/36035165 http://dx.doi.org/10.3389/fgene.2022.896749 Text en Copyright © 2022 Taha, Foroni, Valli, Frattini, Roccia, Porta, Zecca, Bergami, Cipolli, Pasquali, Danesino, Scotti and Minelli. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Taha, Ibrahim
Foroni, Selena
Valli, Roberto
Frattini, Annalisa
Roccia, Pamela
Porta, Giovanni
Zecca, Marco
Bergami, Elena
Cipolli, Marco
Pasquali, Francesco
Danesino, Cesare
Scotti, Claudia
Minelli, Antonella
Case Report: Heterozygous Germline Variant in EIF6 Additional to Biallelic SBDS Pathogenic Variants in a Patient With Ribosomopathy Shwachman–Diamond Syndrome
title Case Report: Heterozygous Germline Variant in EIF6 Additional to Biallelic SBDS Pathogenic Variants in a Patient With Ribosomopathy Shwachman–Diamond Syndrome
title_full Case Report: Heterozygous Germline Variant in EIF6 Additional to Biallelic SBDS Pathogenic Variants in a Patient With Ribosomopathy Shwachman–Diamond Syndrome
title_fullStr Case Report: Heterozygous Germline Variant in EIF6 Additional to Biallelic SBDS Pathogenic Variants in a Patient With Ribosomopathy Shwachman–Diamond Syndrome
title_full_unstemmed Case Report: Heterozygous Germline Variant in EIF6 Additional to Biallelic SBDS Pathogenic Variants in a Patient With Ribosomopathy Shwachman–Diamond Syndrome
title_short Case Report: Heterozygous Germline Variant in EIF6 Additional to Biallelic SBDS Pathogenic Variants in a Patient With Ribosomopathy Shwachman–Diamond Syndrome
title_sort case report: heterozygous germline variant in eif6 additional to biallelic sbds pathogenic variants in a patient with ribosomopathy shwachman–diamond syndrome
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411639/
https://www.ncbi.nlm.nih.gov/pubmed/36035165
http://dx.doi.org/10.3389/fgene.2022.896749
work_keys_str_mv AT tahaibrahim casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome
AT foroniselena casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome
AT valliroberto casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome
AT frattiniannalisa casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome
AT rocciapamela casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome
AT portagiovanni casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome
AT zeccamarco casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome
AT bergamielena casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome
AT cipollimarco casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome
AT pasqualifrancesco casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome
AT danesinocesare casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome
AT scotticlaudia casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome
AT minelliantonella casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome